Novonesis (Novozymes A/S)
19.8.2026 17:39:40 CEST | Globenewswire | Press release
Increased outlook for 2026
Increased outlook for 2026
Novonesis increases its full year 2026 organic sales growth outlook from 5-7% to now 7-8% based on a stronger performance so far in the year and the expectations for the rest of the year. Following the stronger sales growth outlook, the adjusted EBITDA margin is now expected to be at the higher end of the 37-38% range.
The H1 2026 announcement will be announced on August 19, 2026.
Publication of inside information pursuant to Market Abuse Regulation, Article 17.
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Constellation Brands, Inc.8.9.2026 23:15:00 CEST | Press release
Constellation Brands Announces Delivery of Notice of Redemption for 4.350% Senior Notes Due 2027
Atlantic Petroleum P/F8.9.2026 22:59:23 CEST | Press release
Atlantic Petroleum – Result of the Extraordinary General Meeting 8th September 2026
INVENTIVA8.9.2026 22:00:00 CEST | Press release
Inventiva to Present Multiple Abstracts at Paris MASH 2026
Genmab A/S8.9.2026 20:43:58 CEST | Press release
Capital Increase in Genmab as a Result of Employee Warrant Exercise
My green lab8.9.2026 19:51:22 CEST | Press release
My Green Lab Expands ACT Ecolabel Channel Partner Network Ahead of New EU Environmental Claims Rules
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom